1. Chest Computed Tomography and Severity Markers in COVID-19
- Author
-
Gisel Viviana Licón Martínez, MD, Aranza Elena García Aréstegui, MD, Marina Estrada-Rodriguez, Katya Lorena Wilhelmy-Ledesma, Joaquin Córdova Erberk, Gabriel Rocha-González,MD, Fernando Augusto Domínguez-García, MD, Miguel Angel Gaxiola-García, MD, MSc, and Hiram Javier Jaramillo-Ramírez, MD
- Subjects
Coronavirus infections, Pneumonia, Severity Markers, Computed Tomography, Medical Imaging, Pandemics - Abstract
Background:Computed Tomography chest scan can be a tool for classification of COVID 19 disease. We propose there is a relation between computed tomography severity index and inflammation biomarkers.Methods:Weperformed a retrospective analysis of hospitalized COVID 19 patients in Mexicali ́s General Hospital, during the period of March 2020 to December 2020. The inclusion criteria wasover 18 years old, confirmatory RT-PCR nasal swab and available CT chest scan. We extracteddata ofmedical records;variables studied were age, sex, date of symptom onset, date of admission, chest computed tomography score, RT-PCR result, laboratory values (D-dimer, fibrinogen, ferritin, procalcitonin, C-reactive protein, total leukocytes, lymphocytes), and outcome. Results:From March 2020 to December 2020, 397 patients were recruited that fulfilled the inclusion criteria from a 700 patient database. Statistically significant differences after ttests between survivors and non-survivors were found for C-reactive protein (means 47.1 ± 36 vs. 80.1 ± 54;p = 0.0009), procalcitonin (means 961 ± 279 vs. 1,032 ± 283; p = 0.023), white blood cells (means 10.57 ± 4.46 vs. 12.33 ± 6.22; p = 0.0026) and lymphocytes (means 0.79 ± 0.50 vs. 0.68 ± 0.40; p value= 0.026).Conclusions:Laboratory and imaging studies are fundamental for stratification and outcome prediction in COVID-19 patients. With these findings we can determine the prognosis of a patient, have a better approach, and search specifically for the relevant severity markers such as fibrinogen, white blood cells, lymphocytes, and C-reactive protein in hospitals with limited resources.
- Published
- 2021